Dr. He is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 E 28th St
Ste 401
Minneapolis, MN 55407Phone+1 612-863-0200Fax+1 612-273-4098
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 2015 - 2018- University of MinnesotaResidency, Internal Medicine, 2012 - 2015
Geisel School of Medicine at DartmouthClass of 2012
Certifications & Licensure
MN State Medical License 2013 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 33 citationsChemotherapy and Beyond: Infections in the Era of Old and New Treatments for Hematologic Malignancies.Sarah L.P. Atkins, Fiona He
Infectious Disease Clinics of North America. 2019-06-01 - 5 citationsHigh risk of relapse with intermediate dose cytarabine for consolidation in young favourable-risk acute myeloid leukaemia patients following induction with 7+3: a retr...Bhaskar Kolla, Nurul Aidah Abdul Halim, Qing Cao, Zohar Sachs, Erica D. Warlick
British Journal of Haematology. 2021-04-11 - 19 citationsFacilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factorShernan G. Holtan, Andrea Hoeschen, Qing Cao, Mukta Arora, Veronika Bachanova
Blood Advances. 2020-04-14
Journal Articles
- Low Day +100 Serum Epidermal Growth Factor Levels Are Associated With Acute Graft Versus Host Disease After Allogeneic Hematopoietic Cell TransplantationHe F, Verneris M, Cooley S, Blazar B, MacMillan M, Newell L , Panoskaltsis-Mortari A, Weisdorf DJ, Holtan S, Bone Marrow Transplant, 11/21/2016
Abstracts/Posters
- Cell Type-Specific Effects of Crizotinib in Human Acute Myeloid Leukemia with TP53 AlterationsFiona He, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer Cells (NAM-NK) in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multip...Fiona He, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
